MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 42 filers reported holding MUSTANG BIO INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $33,000 | -46.8% | 32,790 | -12.8% | 0.00% | – |
| Q4 2021 | $62,000 | -38.6% | 37,583 | 0.0% | 0.00% | – |
| Q3 2021 | $101,000 | -68.3% | 37,583 | -60.9% | 0.00% | – |
| Q2 2021 | $319,000 | +26.1% | 96,211 | +26.3% | 0.00% | – |
| Q1 2021 | $253,000 | -12.2% | 76,151 | 0.0% | 0.00% | – |
| Q4 2020 | $288,000 | +110.2% | 76,151 | +75.6% | 0.00% | – |
| Q3 2020 | $137,000 | -0.7% | 43,356 | 0.0% | 0.00% | – |
| Q2 2020 | $138,000 | +19.0% | 43,356 | 0.0% | 0.00% | – |
| Q1 2020 | $116,000 | -33.7% | 43,356 | +1.2% | 0.00% | – |
| Q4 2019 | $175,000 | +25.0% | 42,860 | 0.0% | 0.00% | – |
| Q3 2019 | $140,000 | -11.4% | 42,860 | 0.0% | 0.00% | – |
| Q2 2019 | $158,000 | +81.6% | 42,860 | +68.1% | 0.00% | – |
| Q1 2019 | $87,000 | +16.0% | 25,496 | 0.0% | 0.00% | – |
| Q4 2018 | $75,000 | -50.7% | 25,496 | 0.0% | 0.00% | – |
| Q3 2018 | $152,000 | -13.6% | 25,496 | 0.0% | 0.00% | – |
| Q2 2018 | $176,000 | – | 25,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,375,000 | $12,420,000 | 0.88% |
| FNY Investment Advisers, LLC | 200,000 | $736,000 | 0.22% |
| 683 Capital Management, LLC | 625,000 | $2,300,000 | 0.21% |
| HIGHLAND CAPITAL MANAGEMENT LP | 350,000 | $1,288,000 | 0.08% |
| B. Riley Wealth Advisors, Inc. | 107,874 | $397,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 176,400 | $650,000 | 0.02% |
| Quinn Opportunity Partners LLC | 35,514 | $131,000 | 0.02% |
| Frontier Wealth Management LLC | 29,510 | $109,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 15,031 | $55,000 | 0.01% |
| Alyeska Investment Group, L.P. | 165,811 | $610,000 | 0.01% |